Haleon was formed in 2019 by merging GSK and Pfizer's consumer healthcare businesses. It was spun out and listed on the London Stock Exchange in July 2022.
(Reporting by Anchal Rana in Bengaluru; Editing by Tasim Zahid)
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,502 GBX | -1.56% |
|
-5.83% | +3.57% |
01:38pm | GSK : Jefferies maintains a Buy rating | ZD |
12:24pm | Delaware Judge Rejects Drugmakers' Appeal to End Zantac Lawsuits | MT |
(Reuters) - GSK will sell a 3.2% stake, or about 300 million shares, in its spun-off consumer healthcare business Haleon, the British drugmaker said on Tuesday .
Haleon was formed in 2019 by merging GSK and Pfizer's consumer healthcare businesses. It was spun out and listed on the London Stock Exchange in July 2022.
(Reporting by Anchal Rana in Bengaluru; Editing by Tasim Zahid)
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
8,133 PTS | -0.41% | -1.40% | - | ||
1,502 GBX | -1.56% | -5.83% | 78.65B | ||
321.5 GBX | -0.99% | -3.46% | 37.47B | ||
28.22 USD | +0.86% | -0.49% | 160B | ||
1st Jan change | Capi. | |
---|---|---|
+3.57% | 78.65B | |
+56.86% | 823B | |
+41.87% | 641B | |
-6.57% | 352B | |
+17.32% | 324B | |
+9.94% | 301B | |
+15.34% | 241B | |
+1.72% | 223B | |
+13.54% | 218B | |
+7.98% | 167B |